Author:
Chang Zhenglin,Hu Haisheng,Pan Xiaocong,Liu Changlian,Liu Kemin,Zhang Yanxi,Xu Shiliang,Cheng Jiahao,Zhang Qitai,Wan Qiongqiong,Xiao Lexin,Liang Xueqing,Huang Huimin,Cheng Zhangkai J.,Sun Baoqing
Abstract
AbstractResearch has shown that the concentration and composition of biological samples may change after long-term ultra-low temperature storage. Consequently, this study examined the effect of ultra-low temperature storage on serum sIgE detection by comparing sIgE concentrations at various durations from the time of sample storage to subsequent testing. We selected 40 serum samples from the Guangzhou Medical University Affiliated First Hospital Biobank, which had been tested for house dust mites, dog hair, tobacco mold, cockroaches, and cow milk allergen sIgE. Samples were categorized by storage duration: 14 samples stored for 10 years, 12 for 5 years, and 14 for 3 years. They were also classified by sIgE positive levels: 15 samples at levels 1–2, 15 at levels 3–4, and 10 at levels 5–6. The allergen sIgE of these samples was retested using the same technology. Regardless of the type of allergen or the level of positivity, the majority of sIgE concentrations measured at the time of storage were higher than the current measurements, but the difference was not statistically significant. The correlation between the sIgE results at the time of storage and the current results was high for samples stored for 10 years (rs = 0.991, P < 0.001) and 5 years (rs = 0.964, P < 0.001). Serum allergen sIgE is stable when stored under ultra-low temperature conditions, making the construction of a biological sample bank for allergic diseases feasible. This will facilitate researchers in quickly obtaining samples, conducting technical research, and translating findings, thereby promoting the development of the field of allergy through integration of industry, academia, and research.
Funder
Zhong Nanshan Medical Foundation of Guangdong Province
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Abrams, E. M. et al. Pros and cons of pre-emptive screening programmes before peanut introduction in infancy. Lancet Child Adolesc. Health 4(7), 526–535 (2020).
2. Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K. & Irvine, A. D. Atopic dermatitis. Nat. Rev. Dis. Primers 4(1), 1 (2018).
3. Bousquet, J. et al. Allergic rhinitis. Nat. Rev. Dis. Primers 6(1), 95 (2020).
4. Shin, Y. H. et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy 78, 2232–2254 (2023).
5. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 8(6), 585–596 (2020).